Skip to main content

Kevin G. Lafond

Chief Accounting Officer

Alaunos Therapeutics, Inc. (TCRT)

Equibles does not estimate personal net worth.

Get an email with a short summary when Alaunos Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get TCRT alerts

About Kevin G. Lafond

Kevin G. Lafond is recorded as Chief Accounting Officer at Alaunos Therapeutics, Inc. (TCRT). The newest filing on record that lists Kevin G. Lafond as Chief Accounting Officer at Alaunos Therapeutics, Inc. (TCRT) is dated April 7, 2021. The proxy statement of Alaunos Therapeutics, Inc. reports total compensation of $843,123 for Kevin G. Lafond in fiscal 2019, including a base salary of $290,000. Disclosed compensation is on record for 3 fiscal years. Alaunos Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Alaunos Therapeutics, Inc. includes Dale Curtis Hogue, Jr. (CEO and Board Member), Heidi Hagen (CEO and Board Member), Holger Weis (CEO, Chairman and Board Member) and 7 others.

Affiliation history

Company network

Leadership on record at Alaunos Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2019 Alaunos Therapeutics, Inc. (TCRT) $290,000 $843,123
2018 Alaunos Therapeutics, Inc. (TCRT) $283,250 $398,998
2017 Alaunos Therapeutics, Inc. (TCRT) $275,000 $581,224

Recent activity

No call appearances or filed executive changes recorded yet.